Interrogating the tumor microenvironment (TME) in patients (pts) with head and neck mucosal squamous cell carcinoma (HNmSCC) treated with programmed death-1 (PD-1) inhibitors

被引：0
|
作者：
Ferguson, Angela L.
Beddow, Thomas
Patrick, Ellis
Willie, Elijah
Elliott, Michael
Low, Tsu-Hui
Wykes, James
Palme, Carsten
Clark, Jonathan
Hui, Mun Ngah
Palendira, Umaimainthan
Gupta, Ruta
Lee, Jenny H. J.
机构：
[1] Univ Sydney, Centenary Inst, Sydney, NSW, Australia
[2] Univ Sydney, Sydney, NSW, Australia
[3] Chris OBrien Lifehouse, Sydney, NSW, Australia
[4] Chris OBrien Lifehouse, Camperdown, NSW, Australia
[5] NSW Hlth Pathol, Sydney, NSW, Australia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
基金：
澳大利亚国家健康与医学研究理事会;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6048
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Programmed death 1 (PD-1) and ligand (PD-L1) inhibitors in head and neck squamous cell carcinoma: A meta-analysis
    Levy, Dylan A.
    Patel, Jaimin J.
    Nguyen, Shaun A.
    Jungbauer, W. Nicholas
    Neskey, David M.
    Cohen, Ezra E. W.
    Paulos, Chrystal M.
    Kaczmar, John A.
    Knochelmann, Hannah M.
    Day, Terry A.
    WORLD JOURNAL OF OTORHINOLARYNGOLOGY-HEAD & NECK SURGERY, 2022, 8 (03): : 177 - 186
  • [2] Programmed death 1 (PD-1) and ligand (PD-L1) inhibitors in head and neck squamous cell carcinoma: A meta-analysis
    Levy Dylan A.
    Patel Jaimin J.
    Nguyen Shaun A.
    Jungbauer W. Nicholas
    Neskey David M.
    Cohen Ezra E. W.
    Paulos Chrystal M.
    Kaczmar John A.
    Knochelmann Hannah M.
    Day Terry A.
    世界耳鼻咽喉头颈外科杂志英文版, 2022, 08 (03) : 177 - 186
  • [3] Neuromuscular Complications of Programmed Cell Death-1 (PD-1) Inhibitors
    Justin C. Kao
    Adipong Brickshawana
    Teerin Liewluck
    Current Neurology and Neuroscience Reports, 2018, 18
  • [4] Neuromuscular Complications of Programmed Cell Death-1 (PD-1) Inhibitors
    Kao, Justin C.
    Brickshawana, Adipong
    Liewluck, Teerin
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2018, 18 (10)
  • [5] Initial analysis of the synergy of programmed cell death-1 (PD-1) inhibitor and concurrent chemoradiotherapy treatment for recurrent/metastatic head and neck squamous cell carcinoma patients
    Li, Lu
    Chen, Lu
    Yan, Lu
    Guo, Yueqian
    Li, Fang
    Fan, Ming
    Lan, Mei
    Lai, Xin
    Zhou, Jie
    Huang, Yecai
    Xu, Peng
    Lang, Jinyi
    Feng, Mei
    RADIATION ONCOLOGY, 2023, 18 (01)
  • [6] Initial analysis of the synergy of programmed cell death-1 (PD-1) inhibitor and concurrent chemoradiotherapy treatment for recurrent/metastatic head and neck squamous cell carcinoma patients
    Lu Li
    Lu Chen
    Lu Yan
    Yueqian Guo
    Fang Li
    Ming Fan
    Mei Lan
    Xin Lai
    Jie Zhou
    Yecai Huang
    Peng Xu
    Jinyi Lang
    Mei Feng
    Radiation Oncology, 18
  • [7] Association of B cells in tumor microenvironment (TME) with clinical benefit to programmed cell death protein-1 (PD-1) blockade therapy in esophageal squamous cell carcinoma (ESCC).
    Guo, Jhe-Cyuan
    Hsu, Chia-Lang
    Huang, Yen-Lin
    Lin, Chia-Chi
    Huang, Ta-Chen
    Chang, Chun-Jung
    Kuo, Hung-Yang
    Hsu, Chih-Hung
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [8] Nivolumab as Programmed Death-1 (PD-1) Inhibitor for Targeted Immunotherapy in Tumor
    Guo, Liting
    Zhang, Haijun
    Chen, Baoan
    JOURNAL OF CANCER, 2017, 8 (03): : 410 - 416
  • [9] Tumor hypoxia is associated with resistance to PD-1 blockade in squamous cell carcinoma of the head and neck
    Zandberg, Dan P.
    Menk, Ashley V.
    Velez, Maria
    Normolle, Daniel
    DePeaux, Kristin
    Liu, Angen
    Ferris, Robert L.
    Delgoffe, Greg M.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (05)
  • [10] The efficacy of cetuximab plus PD-1 inhibitors as salvage therapy in PD-1 refractory patients with recurrent or metastatic head and neck squamous cell carcinoma
    Hui, Rongrong
    Liu, Xiulan
    Fan, Zongyu
    Ji, Honghai
    Wei, Dongliang
    Ren, Guoxin
    JOURNAL OF CANCER, 2024, 15 (06): : 1668 - 1674
12345